Tradestie Institutional Equity Comparison Engine
NGEN vs SLSN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SLSN Overall Edge
SLSN Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solesence, Inc. Common Stock (SLSN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NGEN trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus SLSN at 11.4x Forward P/E and 4.5% operating margin (+38.1% YoY). In options structure, NGEN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLSN sits in CONSOLIDATION (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SLSN
NGEN N/M vs SLSN 11.4x Fwd P/E
Growth & Margin Winner
SLSN
Op Margin N/A vs 4.5% ยท YoY N/A vs +38.1%
Momentum & Technical Winner
SLSN
1Y -69.5% vs -2.4% ยท 52W Pos 11% vs 58%
Options & Structure Winner
SLSN
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (N/A IV)
NGEN
US Equity
NGEN
Institutional Equity
$1.82
-3.19% 1D
Market Cap
N/A
1M Return
+14.47%
1Y Return
-69.51%
Forward P/E
N/M
Unified AI Score
34.7 / 100
SELL
Tech 15.0
Fund 34.0
Flow 50.0
Mom 40.0
SLSN
NASDAQ
Solesence, Inc. Common Stock
Perfumes, Cosmetics & Other Toilet Preparations
$1.60
+5.26% 1D
Market Cap
$107.4M
1M Return
+77.78%
1Y Return
-2.44%
Forward P/E
11.4x
Unified AI Score
37.1 / 100
SELL
Tech 15.0
Fund 37.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NGEN -69.51%
SLSN -2.44%
Spread: +74.09 pp (SLSN Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
NGEN TTM Op. Margin: N/A
SLSN TTM Op. Margin: 4.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on NGEN vs SLSN. Trailing 12-month operating profitability (NGEN N/A vs SLSN 4.5%) and valuation multiples (NGEN N/M vs SLSN 11.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NGEN | SLSN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $107.4M | Larger Scale | SLSN |
| Trailing P/E Ratio Valuation | N/M | 50.7x | Lower Multiple | SLSN |
| Forward P/E Ratio Valuation | N/M | 11.4x | Lower Multiple | SLSN |
| Revenue Growth (YoY) Growth | N/A | +38.1% | Higher Growth | SLSN |
| Operating Margin (TTM) Profitability | N/A | 4.5% | Higher Margin | SLSN |
| Net Profit Margin Profitability | N/A | 3.0% | Higher Margin | SLSN |
| Return on Equity (ROE) Capital Efficiency | N/A | 10.7% | Higher ROE | SLSN |
| 52-Week Range Position Momentum | 11% ($1โ$6) | 58% ($1โ$2) | Stronger Trend | SLSN |
| Beta / 30D Volatility Risk Regime | 1.25ฮฒ ยท 101% Vol | 1.44ฮฒ ยท 238% Vol | Lower Realized Risk | NGEN |
| Unified Institutional Score Composite Signal | 34.7 / 100 (SELL) | 37.1 / 100 (SELL) | Higher Composite | SLSN |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NGEN vs SLSN Buy Guide
NGEN
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SLSN
CONSOLIDATION
130d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NGEN nor SLSN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.